KRISTALLINE FORM EINES PLEUROMUTILINS
European patent · EP2576505 · In force
Register entry
- Publication number
- EP2576505
- Application number
- EP11724938
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 23, 2011
- Published
- Apr 10, 2013
- Granted
- Nov 29, 2017
- Protection ends at the latest
- May 22, 2031
- Next annual fee due
- May 31, 2027
- IPC classes
- C07C 323/52 (2006.01)A61K 31/215 (2006.01)A61P 17/00 (2006.01)A61P 31/00 (2006.01)
- Priority
- EP 10450092 26.05.2010
- PCT application
- PCT/AT2011/000237 23.05.2011
- PCT publication
- WO2011/146954 01.12.2011
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 1, 2026
Change
Published in Swissreg on 01.06.2026
- Jun 1, 2025
Change
Published in Swissreg on 01.06.2025
- Oct 22, 2024
Change
Published in Swissreg on 22.10.2024
- Sep 4, 2023
Address changed
- Representative
- BOHEST AG, Zweigniederlassung Ostschweiz, Postfach 147, 9471 Buchs → BOHEST AG, Zweigniederlassung Ostschweiz, Postfach, 9471 Buchs
Published in Swissreg on 04.09.2023
- Jun 2, 2023
Change
Published in Swissreg on 02.06.2023
- Feb 6, 2018
Address changed
- Owner
- Nabriva Therapeutics AG, Leberstrasse 20, 1110 Wien, Austria → Nabriva Therapeutics GmbH, Leberstrasse 20, 1110 Wien, Austria
Published in Swissreg on 06.02.2018
- Jan 16, 2018
Agent entered
- Representative
- BOHEST AG, Zweigniederlassung Ostschweiz, Postfach 147, 9471 Buchs
Published in Swissreg on 16.01.2018
- Nov 29, 2017
Granted
Published in Swissreg on 29.11.2017
Parties
Inventor
1220 Wien, AT
7034 Zillingtal, AT
1230 Wien, AT
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.